» Articles » PMID: 29024797

NLRX1 Modulates Differentially NLRP3 Inflammasome Activation and NF-κB Signaling During Fusobacterium Nucleatum Infection

Overview
Journal Microbes Infect
Publisher Elsevier
Date 2017 Oct 13
PMID 29024797
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

NOD-like receptors (NLRs) play a large role in regulation of host innate immunity, yet their role in periodontitis remains to be defined. NLRX1, a member of the NLR family that localizes to mitochondria, enhances mitochondrial ROS (mROS) generation. mROS can activate the NLRP3 inflammasome, yet the role of NLRX1 in NLRP3 inflammasome activation has not been examined. In this study, we revealed the mechanism by which NLRX1 positively regulates ATP-induced NLRP3 inflammasome activation through mROS in gingival epithelial cells (GECs). We found that depletion of NLRX1 by shRNA attenuated ATP-induced mROS generation and redistribution of the NLRP3 inflammasome adaptor protein, ASC. Furthermore, depletion of NLRX1 inhibited Fusobacterium nucleatum infection-activated caspase-1, suggesting that it also inhibits the NLRP3 inflammasome. Conversely, NLRX1 also acted as a negative regulator of NF-κB signaling and IL-8 expression. Thus, NLRX1 stimulates detection of the pathogen F. nucleatum via the inflammasome, while dampening cytokine production. We expect that commensals should not activate the inflammasome, and NLRX1 should decrease their ability to stimulate expression of pro-inflammatory cytokines such as IL-8. Therefore, NLRX1 may act as a potential switch with regards to anti-microbial responses in healthy or diseased states in the oral cavity.

Citing Articles

Commensalism of - The dilemma.

Nayak S, Shetty N, Kamath D J Indian Soc Periodontol. 2025; 28(4):427-430.

PMID: 40018722 PMC: 11864332. DOI: 10.4103/jisp.jisp_286_23.


Periodontal pathogens and cancer development.

Zhou Y, Meyle J, Groeger S Periodontol 2000. 2024; 96(1):112-149.

PMID: 38965193 PMC: 11579836. DOI: 10.1111/prd.12590.


About a Possible Impact of Endodontic Infections by or on Oral Carcinogenesis: A Literature Overview.

Ciani L, Libonati A, Dri M, Pomella S, Campanella V, Barillari G Int J Mol Sci. 2024; 25(10).

PMID: 38791123 PMC: 11121237. DOI: 10.3390/ijms25105083.


Oral microbiota-host interaction: the chief culprit of alveolar bone resorption.

Xu J, Yu L, Ye S, Ye Z, Yang L, Xu X Front Immunol. 2024; 15:1254516.

PMID: 38455060 PMC: 10918469. DOI: 10.3389/fimmu.2024.1254516.


Mitochondrial Dysfunction in Periodontitis and Associated Systemic Diseases: Implications for Pathomechanisms and Therapeutic Strategies.

Deng Y, Xiao J, Ma L, Wang C, Wang X, Huang X Int J Mol Sci. 2024; 25(2).

PMID: 38256098 PMC: 10816612. DOI: 10.3390/ijms25021024.


References
1.
Shao B, Xu Z, Han B, Su D, Liu C . NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol. 2015; 6:262. PMC: 4633676. DOI: 10.3389/fphar.2015.00262. View

2.
Lei Y, Wen H, Ting J . The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy. Autophagy. 2013; 9(3):432-3. PMC: 3590269. DOI: 10.4161/auto.23026. View

3.
ONeill L . Innate immunity: squelching anti-viral signalling with NLRX1. Curr Biol. 2008; 18(7):R302-4. DOI: 10.1016/j.cub.2008.02.021. View

4.
Zhou R, Yazdi A, Menu P, Tschopp J . A role for mitochondria in NLRP3 inflammasome activation. Nature. 2010; 469(7329):221-5. DOI: 10.1038/nature09663. View

5.
Tattoli I, Carneiro L, Jehanno M, Magalhaes J, Shu Y, Philpott D . NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 2008; 9(3):293-300. PMC: 2267388. DOI: 10.1038/sj.embor.7401161. View